Read more
CD7 Directed CAR-T Cell Therapy Proves Highly Effective for T-Cell Malignancies like T-ALL

In a groundbreaking development in the field of hematology and immunotherapy, CD7 directed CAR-T cell therapy has demonstrated remarkable efficacy in treating T-cell malignancies, including T-cell acute lymphoblastic leukemia (T-ALL). This innovative treatment offers new hope for patients with relapsed or refractory T-cell leukemia, as evidenced by the case of Yesheng, a patient who achieved complete remission following this advanced therapy.